It Seems RESVERLOGIX CORP (OTCMKTS:RVXCF) Will Go Up. Just Reported Less Shorted Shares

October 22, 2018 - By Louis Casey

The stock of RESVERLOGIX CORP (OTCMKTS:RVXCF) registered a decrease of 9.43% in short interest. RVXCF’s total short interest was 335,300 shares in October as published by FINRA. Its down 9.43% from 370,200 shares, reported previously. With 31,500 shares average volume, it will take short sellers 11 days to cover their RVXCF’s short positions.

The stock increased 2.41% or $0.06 during the last trading session, reaching $2.55. About 19,975 shares traded. Resverlogix Corp. (OTCMKTS:RVXCF) has 0.00% since October 22, 2017 and is . It has underperformed by 15.62% the S&P500.

Resverlogix Corp., an epigenetics company, develops small molecule therapeutics for bromodomain and extra-terminal inhibition in the United States and Canada. The company has market cap of $482.28 million. It is developing apabetalone (RVX-208), a small molecule selective BET bromodomain inhibitor that is in clinical trials for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases. It currently has negative earnings.